RPRX
Royalty Pharma plc
Company Overview
| Mkt Cap | $16.11B | Price | $37.54 |
| Volume | 3.77M | Change | +1.62% |
| P/E Ratio | 18.8 | Open | $36.83 |
| Revenue | $2.3B | Prev Close | $36.94 |
| Net Income | $859.0M | 52W Range | $24.05 - $38.00 |
| Div Yield | 0.88% | Target | $44.14 |
| Overall | 81 | Value | 100 |
| Quality | 55 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyRoyalty Pharma plc (RPRX) is a leading Manufacturing company in the Medicinal and Botanical Manufacturing industry, currently trading at $37.54 with a market capitalization of $16.11 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows RPRX with a volume of 3.77 million shares. The stock opened down 0.30% from yesterday's close of $36.94. Current analyst estimates project earnings of $4.52 per share for this year, with next year targeting $5.01.
RPRX demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ANIP, ABT, LLY, SPHS.
Key investment considerations for RPRX include excellent overall investment profile. The company offers a dividend yield of 0.88% and analyst price targets suggest potential upside of 17.6%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 07:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RPRX | $37.54 | +1.6% | 3.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |